Type I interferon signaling in systemic immune cells from patients with alcoholic cirrhosis and its association with outcome - CRI

Rechercher Intranet

Auteurs

Emmanuel Weiss,

Pierre-Emmanuel Rautou,

Fasseu M,

Giabicani M,

De Chambrun M,

Minsart C,

Thierry Gustot,

Alain Couvineau,

Maiwall,

Margarita Hurtado-Nedelec,

Pilard N,

Lebrec D,

Dominique Valla,

François Durand,

De La Grange P,

Renato Monteiro,

Catherine Paugam-Burtz,

Sophie Lotersztajn,

Richard Moreau,

Autres publications

Genetic predisposition to porto-sinusoidal vascular disorder

Hepatology.

01 Fév 2026

Auteurs :

Nadia Ciriaci,

Lise Bertin,

Pierre-Emmanuel Rautou,

Elexacaftor-tezacaftor-ivacaftor and cystic fibrosis liver disease: A turning point that calls for cautious optimism

JHEP Rep

26 Nov 2025

Auteurs :

Pierre-Emmanuel Rautou,

Sophie Hillaire,

Simone Gambazza,

Carla Colombo,

EASL Clinical Practice Guidelines on vascular diseases of the liver

J Hepatol.

12 Nov 2025

Auteurs :

Pierre-Emmanuel Rautou,

Lucile Moga,

Virginia Hernandez-Gea,

Walter Ageno,

Sarwa Darwish Murad,

Juan-Carlos Garcia-Pagan,

Maria Guido,

Valérie McLin,

Dhiraj Tripathi,

Valérie Vilgrain,

European Association for the Study of the Liver,

Liver biopsy quality criteria to exclude cirrhosis in case of suspicion of porto-sinusoidal vascular disorder

JHEP Reports

09 Nov 2025

Auteurs :

Chloé de Broucker,

Valérie Paradis,

Maria Luisa Botero,

Miguel Albuquerque,

Audrey Payancé,

Aurélie Plessier,

Laure Elkrief,

François Durand,

Sophie Hillaire,

Paul-Emile Zafar,

Juan Carlos Garcia Pagan,

Pierre-Emmanuel Rautou,